View Author
stent patient scaffold month follow-up strut lesion vessel trial study analysis artery change implantation diameter lumen serruy device curvature everolimu result angulation plaque angiographic group serruys pw bioresorbable 6 months signi value everolimus-eluting cohort baseline difference abbott recoil segment nobori scaffold area stent thrombosis ultrasound intravascular imaging angiography cardiol intervention tissue 12 months table drug-eluting balloon coherence tomography outcome restenosi procedure stenosi thrombosis comparison netherland ficant neointimal regar e polymer figure hospital 12- month follow-up reduction swets subs service xience target coherence hyperechogenicity everolimus bvs ivus-vh tomography geometry event drug-eluting stents assessment 6- month follow-up
10 Most Recent Publications
|
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography
(Article)
Gomez-Lara, J. Brugaletta, S. Dudek, D. Smits, P.C. Chevalier, B. Regar, E.S. Veldhof, S. Rapoza, R. Ormiston, J.A. Garcia-Garcia, H.M. Serruys, P.W.J.C. Farooq, V. Onuma, Y. Diletti, R. Windecker, S. Thuesen, L. McClean, D. Koolen, J. Whitbourn, R. |
2011-12-01
|
|
Serial in vivo intravascular ultrasound-based echogenicity changes of everolimus-eluting bioresorbable vascular scaffold during the first 12 months after implantation: Insights from the ABSORB B trial
(Article)
Brugaletta, S. Gomez-Lara, J. Windecker, S. Smits, P.C. Bruyne, B. de Whitbourn, R. Meredith, I. Domburg, R.T. van Sihan, K. Winter, S. de Veldhof, S. Miquel-Hébert, K. Serruys, P.W.J.C. Rapoza, R. Garcia-Garcia, H.M. Ormiston, J.A. Bruining, N. Farooq, V. Geuns, R-J.M. van Thuesen, L. Dudek, D. Koolen, J. Chevalier, B. McClean, D. |
2011-12-01
|
|
Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold
(Article)
Brugaletta, S. Gomez-Lara, J. Whitbourn, R. Meredith, I. Dorange, C. Veldhof, S. Rapoza, R. Ormiston, J.A. Serruys, P.W.J.C. Garcia-Garcia, H.M. Heo, J.H. Farooq, V. Geuns, R-J.M. van Chevalier, B. Windecker, S. McClean, D. Thuesen, L. |
2011-11-24
|
|
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de Novo Coronary Artery stenosis: 12-month clinical and imaging outcomes
(Article)
Serruys, P.W.J.C. Onuma, Y. Windecker, S. Whitbourn, R. Meredith, I. Dorange, C. Veldhof, S. Hebert, K.M. Sudhir, K. Garcia-Garcia, H.M. Ormiston, J.A. Dudek, D. Smits, P.C. Koolen, J. Chevalier, B. Bruyne, B. de Thuesen, L. McClean, D. Geuns, R-J.M. van |
2011-10-04
|
|
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm
(Article)
Diletti, R. Onuma, Y. Chevalier, B. McClean, D. Windecker, S. Whitbourn, R. Smits, P.C. Koolen, J. Meredith, I. Li, D. Veldhof, S. Rapoza, R. Farooq, V. Garcia-Garcia, H.M. Ormiston, J.A. Serruys, P.W.J.C. Gomez-Lara, J. Brugaletta, S. Geuns, R-J.M. van Regar, E.S. Bruyne, B. de Dudek, D. Thuesen, L. |
2011-07-12
|
|
Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent
(Article)
Onuma, Y. Serruys, P.W.J.C. Windecker, S. Whitbourn, R. Meredith, I. Garcia-Garcia, H.M. Ormiston, J.A. Gomez, J. Bruyne, B. de Dudek, D. Thuesen, L. Smits, P. Chevalier, B. McClean, D. Koolen, J. |
2011-07-01
|
|
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up
(Article)
Gomez-Lara, J. Brugaletta, S. Whitbourn, R. Smits, P.C. Chevalier, B. Morel, M-A.M. Dorange, C. Veldhof, S. Rapoza, R. Garcia-Garcia, H.M. Ormiston, J.A. Serruys, P.W.J.C. Farooq, V. Geuns, R-J.M. van Bruyne, B. de Windecker, S. McClean, D. Thuesen, L. Dudek, D. Koolen, J. |
2011-07-01
|
|
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: Six-month clinical and imaging outcomes
(Article)
Serruys, P.W.J.C. Onuma, Y. Koolen, J. Windecker, S. Whitbourn, R. Meredith, I. Dorange, C. Veldhof, S. Miquel-Hébert, K. Rapoza, R. Garcia-Garcia, H.M. Ormiston, J.A. Bruyne, B. de Regar, E.S. Dudek, D. Thuesen, L. Smits, P.C. Chevalier, B. McClean, D. |
2010-11-30
|
|
A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents
(Article)
Gomez-Lara, J. Garcia-Garcia, H.M. Koolen, J. Whitbourn, R. Smits, P.C. Chevalier, B. Dorange, C. Veldhof, S. Morel, M-A.M. Vries, T. de Ormiston, J.A. Serruys, P.W.J.C. Onuma, Y. Garg, S.A. Regar, E.S. Bruyne, B. de Windecker, S. McClean, D. Thuesen, L. Dudek, D. |
2010-11-01
|
|
Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold
(Article)
Brugaletta, S. Garcia-Garcia, H.M. Chevalier, B. Windecker, S. Whitbourn, R. Dorange, C. Miquel-Hébert, K. Sudhir, K. Ormiston, J.A. Serruys, P.W.J.C. Garg, S.A. Gomez-Lara, J. Diletti, R. Onuma, Y. Geuns, R-J.M. van McClean, D. Dudek, D. Thuesen, L. |
2010-10-13
|
